Aberrant activation of FZD7 has been found in several types of cancer such as breast (Yang et al., 2011), colorectal (Ueno et al., 2009), hepatocellular carcinoma (Merle et al., 2005), and gastric cancer (Kirikoshi et al., 2001). The gene discussed is FZD7; the disease is gastric cancer.